home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

World Drug Discovery and Development Summit

 
  July 18, 2006  
     
 
World Trade Group, Cologne, Germany
5th - 6th December


Hosting over 300 leading senior drug discovery and development professionals, the 6th Annual World Drug Discovery and Development Summit provides a unique opportunity to network and do business with industry peers from all over Europe.

WDD 2006 features case studies from the world’s leading Pharma companies focusing on overcoming scientific and strategic challenges faced in the research and development process.

Topics to be discussed at the World Drug Discovery & Development Summit 2006:

R&D Success – lessons to be learnt
Screening Strategy – target based vs. phenotypic approaches
Biomarkers – are biomarkers really the holy grail of drug discovery?
Alliances – do early partnership offer the key to success in development?
Toxicity – does early ADME/TOX screening reduce attrition rates?
Technology – what is the future of R&D technology and where is it leading?
Who should attend World Drug Discovery and Development Summit 2006?

Vice Presidents, Directors, Heads of responsible for:

R&D
Discovery
Development
Preclinical Development
Screening
Research
Pharmaceutical Development

Scientific Affairs
Toxicology
Product Development
Safety
Technology
Chemistry
Genetics
Medical Affairs

 
 
Organized by: World Trade Group
Invited Speakers: - Dr Hanno Wild
Senior Vice President Discovery Europe, Pharma Global Drug Discovery
Bayer HealthCare AG
- Prof. Ian Wilson
Senior Principal Scientist
AstraZeneca
- Dr Graham Dixon
Senior Vice President, Drug Discovery
Galapagos NV
- Dr Jeffrey Waring
Group Leader, Toxiocogenomics
Abbott Laboratories
-Dr Irina Antonijevic
Director, Translational Research
Lundbeck Research
- Dr Frank Sams-Dodd
Vice President, Preclinical Development
Bionomics
- Dr Jan ter Meulen
Executive Director, Infectious Diseases
Crucell
- Peter O’ Brien
Head of Discovery Toxicology Biomarkers
Pfizer
 
Deadline for Abstracts: none
 
Registration: http://www.wddsummit.com/delegate_reg1.asp
E-mail: Lisa.Wulf@worldtradeco.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.